COSENTYX® (secukinumab) for US HCP

Novartis invites you to learn more about COSENTYX® at cosentyxhcp.com. This product information is intended for US health care professionals only. Please see Full Prescribing Information including Medication Guide for COSENTYX® (secukinumab) at bit.ly/COSHCP. COSENTYX® is a Novartis Pharmaceuticals Corporation brand and is not associated with any individual users on LinkedIn. To report side effects related to Novartis products please visit https://www.report.novartis.com/en, contact Novartis Pharmaceuticals Corporation at 1-888-669-6682 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 8/24 448939